App-Quantinova.ai

Relationship Between Timing of Anticoagulation Initiation and Clinical Outcomes in Acute Venous Thromboembolism Patients Who Received Low Molecular Weight Heparin or Direct Oral Anticoagulants

M. Ahmad - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Heparin

A Single Center Experience of Transitioning Stable Pulmonary Arterial Hypertension Patients from Parenteral Prostacyclin Therapy to Oral Selexipag

T. G. Shah - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Prostacyclin

Risk Factors for Venous Thromboembolism in Critically Ill Patients

N. Panyavachiraporn - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Adjusted GAPSS in Systemic Lupus Erythematosus Patients in Argentina

Maria Victoria Martire - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Hydroxychloroquine

Clinical and Genetic Factors Associated with Thrombosis or Pregnancy Morbidity of Antiphospholipid Antibody-Positive Systemic Lupus Erythematosus Patients

Ga Young Ahn - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Comparison of the Thrombosis Risk Score with Triple Positivity in SLE Thrombosis

Jessica Li - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Early Anticoagulation Improves the Long-term Prognosis in Patients with Antiphospholipid Syndrome Associated Portal Vein Thrombosis

Jiuliang Zhao - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

First Cardiovascular Event in Rheumatoid Arthritis: Do Patients with Venous Thromboembolism Have a Different Risk Profile Than Patients with Atherosclerotic Cardiovascular Disease?

Sofia Pedro - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

How Often Should SLE Patients Be Tested for Lupus Anticoagulant?

Michelle Petri - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Hydroxychloroquine Blood Levels and Risk of Thrombotic Events in Systemic Lupus Erythematous

Jessica Li - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Hydroxychloroquine

Hydroxychloroquine Use and Cardiovascular Events Among Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis

Na Lu - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Hydroxychloroquine

Identifying Additional Risk Factors for Arterial and Venous Thrombosis Among Pediatric Antiphospholipid Antibodies Carriers

Tracey Wright - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Persistency in Platelet C4d and Thrombosis Risk Score Associate with Thrombosis in Systemic Lupus Erythematosus

John Conklin - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Potent Anti-neutrophil Properties of the Natural Compound 6-Gingerol in Models of Lupus and Antiphospholipid Syndrome

Julia Weiner - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Real-World Evidence: Clinical and Economic Burden of Anemia, Venous Thromboembolism, and Malignancy Among Rheumatoid Arthritis Patients Switching from First Biologic DMARD to Another Treatment in the US

Jenya Antonova - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Relationship Between Recurrent Thrombosis and the Antiphospholipid Antibodies Profile in a Cohort of Patients with Antiphospholipid Syndrome

Tomas Urrego - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Rheumatoid Arthritis Associated with Longer Hospital Stays in Patients Admitted with Venous Thromboembolism: A Nationwide Analysis 2010-2014

Karan Jatwani - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Risk of Subsequent Atherosclerotic Cardiovascular Disease After the First Unprovoked Venous Thromboembolism in Patients with Rheumatoid Arthritis

Sofia Pedro - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Risk of Thromboembolism with Janus Kinase Inhibitors: A Systematic Review and Meta-Analysis of Randomized Placebo Controlled Trials

Irbaz Bin Riaz - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Risk of Venous Thromboembolism in Rheumatoid Arthritis Patients Initiating Biologic and Non-biologic DMARDs, a Population-based Study

Na Lu - American College of Rheumatology (ACR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Filters

7277 Abstracts